![]() |
With his group’s new method and the use of artificial intelligence, G.V. Shivashankar hopes to improve tumor diagnosis. Photo Credit: Paul Scherrer Institute/Markus Fischer |
Blood cells reveal tumors in the body. Researchers at the Paul Scherrer Institute achieve an advance with the development of a test for early diagnosis of cancer.
The ability to detect a developing tumor at a very early stage and to closely monitor the success or failure of cancer therapy is crucial for a patient’s survival. A breakthrough on both counts has now been achieved by researchers at the Paul Scherrer Institute PSI. Researchers led by G.V. Shivashankar, head of PSI‘s Laboratory for Nanoscale Biology and professor of Mechano-Genomics at ETH Zurich, were able to prove that changes in the organization of the cell nucleus of some blood cells can provide a reliable indication of a tumor in the body. With their technique – using artificial intelligence – the scientists were able to distinguish between healthy and sick people with an accuracy of around 85 percent. Besides that, they managed to correctly determine the type of tumor disease – melanoma, glioma, or head and neck tumor. “This is the first time anyone, worldwide, has achieved this,” Shivashankar says happily. The researchers have published their results in the journal npj Precision Oncology.